-
06:53:32 AM
Sign in with email
Forgot your password?
Register with email
Account Verification

MRNA - Moderna Inc

09/09/21 7:12 AM
Nasdaq : MRNA
Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced significant advances across its portfolio of mRNA pipeline programs being presented at the Company’ s fifth annual R&D Day today. “I am proud of the progress that the Moderna team has made in advancing our best-in-class mRNA pipeline while addressing...
RHEA-AI
neutral
09/03/21 4:01 PM
Nasdaq : MRNA
covid-19
Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced it has submitted for a conditional marketing approval with the European Medicines Agency for the evaluation of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level. “We are pleased to submit for a conditional marketing approval with...
RHEA-AI
neutral
08/25/21 9:44 AM
Nasdaq : MRNA
covid-19
Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application to the U.S. Food and Drug Administration for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18...
RHEA-AI
neutral